| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 鼻腔护理类产品(元) | 56,410,097.04 | 183,098,947.67 | 82,060,028.24 | 126,104,125.09 | 54,692,968.82 |
| 疼痛管理类产品(元) | 106,917,591.45 | 220,976,748.22 | 95,068,799.87 | 117,391,616.13 | 64,120,169.66 |
| 医疗器械CXO(元) | - | - | 2,184,335.51 | 7,707,564.29 | 3,531,051.64 |
| 代理产品(元) | - | - | - | 72,175,235.07 | - |
| 其他产品(元) | 16,137,552.25 | 16,710,148.85 | 9,383,928.90 | - | 20,348,959.77 |
| 营业成本(元) | |||||
| 鼻腔护理类产品(元) | 13,243,148.56 | 38,649,486.96 | 19,244,149.89 | 21,505,076.23 | 8,566,961.18 |
| 疼痛管理类产品(元) | 30,748,025.61 | 90,497,434.30 | 41,404,551.01 | 67,539,306.31 | 26,626,487.74 |
| 医疗器械CXO(元) | - | - | 1,493,006.73 | 6,694,182.48 | 1,888,873.77 |
| 代理产品(元) | - | - | - | 67,608,312.05 | - |
| 其他产品(元) | 13,091,719.32 | 15,624,455.19 | 9,565,378.27 | - | 18,738,522.06 |
| 毛利(元) | |||||
| 鼻腔护理类产品(元) | 43,166,948.48 | 144,449,460.71 | 62,815,878.35 | 104,599,048.86 | 46,126,007.64 |
| 疼痛管理类产品(元) | 76,169,565.84 | 130,479,313.92 | 53,664,248.86 | 49,852,309.82 | 37,493,681.92 |
| 医疗器械CXO(元) | - | - | 691,328.78 | 1,013,381.81 | 1,642,177.87 |
| 代理产品(元) | - | - | - | 4,566,923.02 | - |
| 其他产品(元) | 3,045,832.93 | 1,085,693.66 | -181,449.37 | - | 1,610,437.71 |
| 毛利率(%) | |||||
| 鼻腔护理类产品(%) | 76.52 | 78.89 | 76.55 | 82.95 | 84.34 |
| 疼痛管理类产品(%) | 71.24 | 59.05 | 56.45 | 42.47 | 58.47 |
| 医疗器械CXO(%) | - | - | 31.65 | 13.15 | 46.51 |
| 代理产品(%) | - | - | - | 6.33 | - |
| 其他产品(%) | 18.87 | 6.50 | -1.93 | - | 7.91 |
| 收入构成(%) | |||||
| 鼻腔护理类产品(%) | 31.43 | 43.51 | 43.49 | 39.00 | 38.33 |
| 疼痛管理类产品(%) | 59.58 | 52.52 | 50.38 | 36.30 | 44.94 |
| 医疗器械CXO(%) | - | - | 1.16 | 2.38 | 2.47 |
| 代理产品(%) | - | - | - | 22.32 | - |
| 其他产品(%) | 8.99 | 3.97 | 4.97 | - | 14.26 |
| 毛利构成(%) | |||||
| 鼻腔护理类产品(%) | 35.27 | 52.33 | 53.69 | 65.36 | 53.10 |
| 疼痛管理类产品(%) | 62.24 | 47.27 | 45.87 | 31.15 | 43.16 |
| 医疗器械CXO(%) | - | - | 0.59 | 0.63 | 1.89 |
| 代理产品(%) | - | - | - | 2.85 | - |
| 其他产品(%) | 2.49 | 0.39 | -0.16 | - | 1.85 |